| Morepen Laboratories Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 500288 |
NSE Symbol : MOREPENLAB |
P/E(TTM) : 37.92 |
|
ISIN Demat : INE083A01026 |
Div & Yield% : 0.26 |
EPS(TTM) : 2.03 |
|
Book Value(₹) : 22.68 |
Market Cap(₹Cr) : 4,217.60 |
Face Value(₹) : 2.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 541.04 | 462.81 | 457.57 | 369.53 | 391.28 | 381.94 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 541.04 | 462.81 | 457.57 | 369.53 | 391.28 | 381.94 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 5.31 | 8.82 | 3.93 | 5.75 | 4.09 | 3.14 |
| Total Income | 546.35 | 471.63 | 461.50 | 375.28 | 395.38 | 385.08 |
| Total Expenditure | 461.44 | 439.50 | 415.68 | 341.60 | 372.33 | 351.78 |
| PBIDT | 84.91 | 32.13 | 45.82 | 33.67 | 23.04 | 33.30 |
| Interest | 4.78 | 3.87 | 4.31 | 4.11 | 3.81 | 3.74 |
| PBDT | 80.13 | 28.26 | 41.52 | 29.57 | 19.23 | 29.56 |
| Depreciation | 7.98 | 0.63 | 10.09 | 10.70 | 7.88 | 12.25 |
| Tax | 18.15 | -0.99 | 7.93 | 4.49 | 3.29 | 0.67 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 8.49 | 0.00 | 0.00 | 0.00 | 4.73 |
| Reported Profit After Tax | 54.00 | 20.12 | 23.50 | 14.38 | 8.06 | 11.91 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.84 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 54.00 | 20.12 | 23.50 | 13.54 | 8.06 | 11.91 |
| EPS (Unit Curr.) | 0.99 | 0.37 | 0.43 | 0.26 | 0.15 | 0.20 |
| EPS (Adj) (Unit Curr.) | 0.99 | 0.37 | 0.43 | 0.26 | 0.15 | 0.20 |
| Calculated EPS (Unit Curr.) | 0.99 | 0.37 | 0.43 | 0.26 | 0.15 | 0.22 |
| Calculated EPS (Adj) (Unit Curr.) | 0.99 | 0.37 | 0.43 | 0.26 | 0.15 | 0.22 |
| Calculated EPS (Ann.) (Unit Curr.) | 3.94 | 1.47 | 1.72 | 1.05 | 0.59 | 0.87 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 3.94 | 1.47 | 1.72 | 1.05 | 0.59 | 0.87 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 109.58 | 109.58 | 109.58 | 109.58 | 109.58 | 109.58 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 15.69 | 6.94 | 10.01 | 9.11 | 5.89 | 8.72 |
| PBDTM(%) | 14.81 | 6.11 | 9.07 | 8.00 | 4.91 | 7.74 |
| PATM(%) | 9.98 | 4.35 | 5.14 | 3.89 | 2.06 | 3.12 |
